Nuvalent Inc. Navigates Financial Challenges Amid Focus on Cancer Therapeutics
Nuvalent Inc. is a biotechnology company specializing in cancer treatments and diagnostics, with a global presence and market capitalization of approximately $5.61 billion.
2 minutes to read